THE DRUGS INSPECTOR vs M/S. FIZIKEN LAB. PVT. TLD.

The Supreme Court held that the Drugs Inspector appointed under Section 21 of the Drugs and Cosmetics Act, 1940, has jurisdiction to prosecute for offences under Section 32 of the Act, including the manufacture and sale of misbranded Ayurvedic drugs. The Court clarified that the lack of a specific license for manufacturing sildenafil citrate does not exempt the respondents from prosecution for violations related to the sale of such drugs. The appeal was allowed, overturning the High Court's decision that limited the Inspector's prosecutorial authority.